相关实验视频
Updated: Jun 17, 2025

04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
7.4K
膝关节整形术后的抗血栓预防:贝叶斯网络的I级元分析
Filippo Migliorini1,2,3,4, Nicola Maffulli5,6,7, Erlis Velaj1
1Department of Orthopaedic, Trauma, and Reconstructive Surgery, RWTH University Medical Centre, 52074, Aachen, Germany.
概括
阿皮克萨班5毫克提供了最好的平衡,防止静脉血栓塞栓症 (VTE) 后全膝关节整形术 (TKA),同时最大限度地降低出血风险. 这一发现有助于为TKA患者选择最佳的药理学预防.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
- 基于证据的医学基于证据的医学.
背景情况:
- 静脉血栓塞栓症 (VTE) 是膝关节全关节整形术 (TKA) 后的一个重大并发症.
- 在TKA后预防VTE的药理学预防的选择是正在进行的辩论的主题.
- 几种非维生素K对抗剂口服抗凝剂 (NOACs) 常用于TKA后的静脉瘤预防.
研究的目的:
- 为了比较各种NOACs在TKA后的VTE预防中的疗效和安全性.
- 评估深静脉栓塞 (DVT),肺栓塞 (PE) 和大/小出血的发生率.
- 为了确定最佳的抗凝剂,平衡VTE预防和出血风险.
主要方法:
- 根据PRISMA指南进行了贝叶斯网络元分析.
- 在2024年3月,对PubMed,科学网和谷歌学者进行了搜索.
- 包括随机对照试验 (RCT),比较两种或多种药物用于TKA后的VTE预防.
主要成果:
- 分析了来自29,678名患者的数据 (67%为女性,平均年龄为66.8岁,平均BMI为29.2kg/m2).
- 阿皮克萨班5毫克,达比加特兰220毫克和里瓦罗克萨班10毫克在减少DVT方面显示出最高的疗效.
- 5毫克的阿皮克萨班,60毫克的埃诺克萨巴林和40毫克的里瓦罗克萨班在降低PE方面最有效.
- 阿皮克萨班 (5毫克和10毫克) 和里瓦罗克萨班10毫克与较低的重大出血率有关.
- 阿皮克萨班 (5毫克和20毫克) 和达比加特兰 (220毫克) 显示了较低的轻微出血率.
结论:
- 5毫克的阿皮克萨班在TKA后的VTE预防和出血控制之间表现出卓越的平衡.
- 这一发现支持阿皮克萨班5毫克作为TKA患者药理学预防的首选药物.
- 这项研究为优化骨科手术中抗凝剂选择提供了有价值的证据.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
502
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
502
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K

